Showing results (1621-1630 of 1,672) with videos related to

Sort By:
Pageof 168
Clinical Genitourinary Cancer|December 19, 2021
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma PatientsDylan J Martini, Sean T Evans, Yuan Liu, et al.
Parkinsonism & Related Disorders|October 15, 2013
Dietary fat intake, pesticide use, and Parkinson's diseaseFreya Kamel, Samuel M Goldman, David M Umbach, et al.
Blood|October 22, 2009
Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutationFranck E Nicolini, Michael J Mauro, Giovanni Martinelli, et al.
Bone Marrow Transplantation|July 1, 1997
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationA Devergie, J F Apperley, M Labopin, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
A semantotopic map in human hippocampusElizabeth A Mickiewicz, Melissa Franch, Kalman A Katlowitz, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2024
Dry-Cleaning Chemicals and a Cluster of Parkinson's Disease and Cancer: A Retrospective InvestigationE Ray Dorsey, Dan Kinel, Meghan E Pawlik, et al.
The New England Journal of Medicine|August 16, 2002
Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor betaJane F Apperley, Martine Gardembas, Junia V Melo, et al.
Blood|March 9, 2006
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing resultsTimothy Hughes, Michael Deininger, Andreas Hochhaus, et al.
NPJ Parkinson'S Disease|March 2, 2021
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonismCaroline M Tanner, Steven R Cummings, Michael A Schwarzschild, et al.
Blood|June 14, 2000
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)R E Champlin, N Schmitz, M M Horowitz, et al.
Pageof 168